What we do Chandan Healthcare Ltd operates advanced labs offering pathology and radiology services across North India, including a 300-bed multi-specialty hospital and a network of retail pharmacies. |
Founded in 2,003 |
Market share Leading diagnostic service provider in North India with NABL and NABH accredited labs and expanding retail pharmacy presence. |
Problem solved Provides accurate, reliable diagnostic testing and healthcare services to support patient care and clinical decisions. |
Top clients or who we serve Primarily B2C patients across Uttar Pradesh, Uttarakhand, and Delhi, hospitals, and retail pharmacy customers. |
Key management - |
Our journey and innovations Started in Lucknow in 2003, expanded labs and retail pharmacies, IPO in 2025 to fund new centers and technology upgrades. |
Where we operate More than 15 cities in Uttar Pradesh, over 10 in Uttarakhand, and locations in Delhi, India-wide presence expanding. |
Top products or what we offer Pathology and specialized pathology tests, radiology services with CT and MRI scans, multi-specialty hospital services. |
Top brands - |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue primarily driven by recurring diagnostic tests and hospital services with steady demand. |
Our industry position Strong regional leader in diagnostic testing with growing multi-specialty hospital and pharmacy verticals. |
Financial highlights FY 2024-25 revenue ₹230 Cr consolidated, net profit ₹22.17 Cr, showing healthy growth year-over-year. |
Geographical revenue split Revenue largely from Uttar Pradesh and Uttarakhand, with increasing footprint in Delhi and nearby regions. |
Order book - |
Whats driving growth Expansion of diagnostic centers, hospital services, retail pharmacies, technological upgrades, and growing healthcare demand. |
Our future plans Investing IPO proceeds into new flagship diagnostic centers and central reference labs in Uttar Pradesh. |
Our green promise - |
Our people and values Employee base of 1,192 with focus on quality, ethics, and patient-centric culture. |
Key challenges ahead Increasing competition, regulatory compliance, and scaling operations efficiently while maintaining quality. |
Interesting facts NABL and NABH accreditations across multiple labs and diagnostic centers; successful IPO oversubscribed 7 times. |
Risks and strategy Risks include market competition and operational scale; strategy involves technological investments and geographic expansion. |
